IP Library Granted Patent US 7,202,339
Granted Patent B2
US 7,202,339 · App. 10/196,655 · Granted Apr 10, 2007

Crystals of MarR polypeptides, regulators of multiple antibiotic resistance

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,202,339
App. No.
10/196,655
Granted
Apr 10, 2007
Kind
B2
Abstract

The crystal structure of the product, crystals of the MarR protein, a regulator of multiple antibiotic resistance in Escherichia coli , and methods of crystallization of the MarR protein are described.

Claims (10)

1. A co-crystallized regulator of multiple antibiotic resistance (MarR) and the inhibitor salicylate having unit cell dimensions of a=62.00 Å, b=62.00 Å and c=132.89 Å, wherein said co-crystallized MarR and salicylate are crystallized under appropriate conditions such that the three dimensional structure of MarR and salicylate can be determined, and wherein said three dimensional structure has/4 1 22 space group and a peptide sequence of MarR comprising SEQ ID NO: 2.

2. The crystallized MarR of claim 1 , wherein said MarR is selected from the group consisting of MarR of Escherichia coli and MarR, of Salmonella typhimurium.

3. The co-crystallized MarR and salicylate of claim 1 , wherein said three dimensional structure is determined to a maximum resolution of 2.3 Å or better.

4. The crystallized MarR of claim 1 , wherein said MarR has a winged-helix structure.

5. A crystallized MarR defined by FIGS. 7-1 to 7 - 20 , wherein the crystal comprises SEQ ID NO: 2 and the inhibitor salicylate.

6. A crystallized MarR defined by FIGS. 8-1 to 8 - 29 , wherein the crystal comprises SEQ ID NO: 2.

7. A crystallized regulator of multiple antibiotic resistance (MarR) having unit cell dimensions of a=65.8 Å, b=137.7 Å and c=96.4 Å, wherein said crystallized MarR is crystallized under appropriate conditions such that the three dimensional structure or said MarR can be determined, and wherein said three dimensional structure has C222 space group and a peptide sequence of MarR comprising SEQ ID NO: 2.

8. The crystallized MarR of claim 7 , wherein said MarR is selected from the group consisting of MarR of Escherichia coli and MarR of Salmonella typhimurium.

9. The crystallized MarR of claim 7 , wherein said MarR has a winged-helix structure.

10. The crystallized MarR of claim 7 , wherein said three dimensional structure is determined to a maximum resolution of 2.3 Å.

Assignments (7)
RELEASE OF SECURITY INTEREST Recorded Oct 31, 2014
From: HBM HEALTHCARE INVESTMENTS (CAYMAN) LTD., AS COLLATERAL AGENT
To: PARATEK PHARMACEUTICALS, INC.
Reel/Frame 034113/0910 →
SECURITY INTEREST Recorded Mar 14, 2014
From: PARATEK PHARMACEUTICALS, INC.
To: HBM HEALTHCARE INVESTMENTS (CAYMAN) LTD., AS COLLATERAL AGENT
Reel/Frame 032448/0001 →
RELEASE OF SECURITY INTEREST Recorded Oct 9, 2009
From: MIDCAP FINANCIAL, LLC
To: PARATEK PHARMACEUTICALS, INC.
Reel/Frame 023348/0621 →
SECURITY AGREEMENT Recorded Jul 6, 2009
From: PARATEK PHARMACEUTICALS, INC.
To: MIDCAP FINANCIAL, LLC
Reel/Frame 022917/0112 →
EXECUTIVE ORDER 9424, CONFIRMATORY LICENSE Recorded Jul 9, 2008
From: TUFTS UNIVERSITY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 021209/0541 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 9, 2003
From: ALEKSHUN, MICHAEL N.; LEVY, STUART B.
To: TRUSTEES OF TUFTS COLLEGE
Reel/Frame 013936/0626 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 9, 2003
From: HEAD, JAMES F.; SEATON, BARBARA A.
To: TRUSTEES OF BOSTON UNIVERSITY
Reel/Frame 013941/0662 →